Ribosomal Protein P2: A Potential Molecular Target for Antisense Therapy of Human Malignancies

Anticancer Research

Volumn 23, Issue 6 C, 2003, Pages 4549-4560

  Gardner Thorpe, James ^a   Ito, Hiromichi ^a   Ashley, Stanley W ^a   Whang, Edward E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

BxPC 3; Cancer; MIA PaCa 2; Ribosomal protein P2; RPLP2

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; F ACTIN; F ACTING CAPPING PROTEIN; LACTATE DEHYDROGENASE; PROTEOME; RHO C PROTEIN; RHO FACTOR; RIBOSOMAL PROTEIN L23A; RIBOSOMAL PROTEIN P2; RIBOSOME PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; VINCULIN;

ARTICLE; CANCER CELL; CANCER THERAPY; CELL GROWTH; CONTROLLED STUDY; DNA MICROARRAY; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

BASE SEQUENCE; BREAST NEOPLASMS; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; L-LACTATE DEHYDROGENASE; NEOPLASM PROTEINS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; RIBOSOMAL PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VINCULIN;

EID: 0842268488     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Gomez-Lorenzo MG, Spahn CM, Agrawal RK et al: Three-dimensional cryo-electron microscopy localization of EF2 in the Saccharomyces cerevisiae 80S ribosome at 17.5 A resolution. Embo J 19: 2710-2718, 2000.
2. Tate WP, Kastner B, Edgar CD et al: The ribosomal domain of the bacterial release factors. The carboxyl-terminal domain of the dimer of Escherichia coli ribosomal protein L7/L12 located in the body of the ribosome is important for release factor interaction. Eur J Biochem 187: 543-548, 1990.
3. Zinker S: P5/P5' the acidic ribosomal phosphoproteins from Saccharomyces cerevisiae. Biochim Biophys Acta 606: 76-82, 1980.
4. Wool IG, Chan YL, Gluck A and Suzuki K: The primary structure of rat ribosomal proteins P0, P1, and P2 and a proposal for a uniform nomenclature for mammalian and yeast ribosomal proteins. Biochimie 73: 861-870, 1991.
5. Zinker S and Warner JR: The ribosomal proteins of Saccharomyces cerevisiae. Phosphorylated and exchangeable proteins. J Biol Chem 251: 1799-1807, 1976.
6. Tchorzewski M, Boldyreff B, Issinger O and Grankowski N: Analysis of the protein-protein interactions between the human acidic ribosomal P-proteins: evaluation by the two hybrid system. Int J Biochem Cell Biol 32: 737-746, 2000.
7. Ballesta J, Guarinos E, Zurdp J, Parada P, Nusspaumer G, Lalioti VS, Perez-Fernadez J and Remacha M: Structure of the Yeast Ribosomal Stalk. Washington, D.C.: ASM Press 115-125, 2000.
8. Santos C and Ballesta JP: Ribosomal protein P0, contrary to phosphoproteins P1 and P2, is required for ribosome activity and Saccharomyces cerevisiae viability. J Biol Chem 269: 15689-15696, 1994.
9. Remacha M, Jimenez-Diaz A, Santos C et al: Proteins P1, P2, and P0, components of the eukaryotic ribosome stalk. New structural and functional aspects. Biochem Cell Biol 73: 959-968, 1995.
10. Remacha M, Jimenez-Diaz A, Bermejo B, Rodriguez-Gabriel MA, Guarinos E and Ballesta JP: Ribosomal acidic phosphoproteins P1 and P2 are not required for cell viability but regulate the pattern of protein expression in Saccharomyces cerevisiae. Mol Cell Biol 15: 4754-4762, 1995.
11. Elvin P, Kerr IB, McArdle CS and Birnie GD: Isolation and preliminary characterisation of cDNA clones representing mRNAs associated with tumour progression and metastasis in colorectal cancer. Br J Cancer 57: 36-42, 1988.
12. Brown MA, Xu CF, Nicolai H et al: The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12: 2507-2513, 1996.
13. Harvie R, Elvin P, McArdle C, Morten JE and McNicol AM: Detection of mRNA for ribosomal phosphoprotein P2 in normal colon and colonic tumours by in situ hybridization. J Pathol 164: 67-73, 1991.
14. Sharp MG, Adams SM, Elvin P, Walker RA, Brammar WJ and Varley JM: A sequence previously identified as metastasis-related encodes an acidic ribosomal phosphoprotein, P2. Br J Cancer 61: 83-88, 1990.
15. Chen A, Kaganovsky E, Rahimipour S, Ben-Aroya N, Okon E and Koch Y: Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res 62: 1036-1044, 2002.
16. Boon K, Caron HN, van Asperen R et al: N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. Embo J 20: 1383-1393, 2001.
17. Aspinall RJ and Lemoine NR: Gene therapy for pancreatic and biliary malignancies. Ann Oncol 10 Suppl 4: 188-192, 1999.
18. Gilliam AD and Watson SA: Emerging biological therapies for pancreatic carcinoma. Eur J Surg Oncol 28: 370-378, 2002.
19. Clemens MJ and Bommer UA: Translational control: the cancer connection. Int J Biochem Cell Biol 31: 1-23, 1999.
20. Caraglia M, Budillon A, Vitale G, Lupoli G, Tagliaferri P and Abbruzzese A: Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. Eur J Biochem 267: 3919-3936, 2000.
21. Gardner-Thorpe J, Ito, H, Ashley SW and Whang EE: Differential display of expressed genes in human pancreatic cancer cell. Biochem Biophys Res Commun, in press.
22. Agrawal S: Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides. Biochim Biophys Acta 1489: 53-68, 1999.
23. Raitano AB, Scuderi P and Korc M: Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells. Pancreas 5: 267-277, 1990.
24. O'Farrell PH: High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021, 1975.
25. Oakley BR, Kirsch DR and Morris NR: A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 105: 361-363, 1980.
26. Feinberg AP and Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137(1): 266-7, 1984.
27. Stein CA: Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments. Biochim Biophys Acta 1489: 45-52, 1999.
28. Remacha M, Santos C, Bermejo B, Naranda T and Ballesta JP: Stable binding of the eukaryotic acidic phosphoproteins to the ribosome is not an absolute requirement for in vivo protein synthesis. J Biol Chem 267: 12061-12067, 1992.
29. Hall A and Nobes CD: Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B Biol Sci 355(1399): 965-70, 2000.
30. Mizejewski GJ: Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222(2): 124-38, 1999.
31. Feldner JC and Brandt BH: Cancer cell motility-on the road from c-erbB-2 receptor steered signaling to actin reorganization. Exp Cell Res 272(2): 93-108, 2002.
32. Yarm FR: Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol Cell Biol 22(17): 6209-21, 2002.
33. Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R and Telerman A: Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci USA 99(23): 14976-81, 2002.
34. Pestova TV, Kolupaeva VG, Lomakin IB, Pilipenko EV, Shatsky IN, Agol VI and Hellen CU: Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci USA 98(13): 7029-36. Review, 2001.
35. Clemens MJ, Bushell M, Jeffrey IW, Pain VM and Morley SJ: Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ 7(7): 603-15, 2000.
36. Ferrari S, Manfredini R, Tagliafico E, Rossi E, Donelli A, Torelli G and Torelli U: Noncoordinated expression of S6, S11, and S14 ribosomal protein genes in leukemic blast cells. Cancer Res 50(18): 5825-8, 1990.
37. Morra E: The biological markers of non-Hodgkin's lymphomas: their role in diagnosis, prognostic assessment and therapeutic strategy. Int J Biol Markers 14(3): 149-53, Review, 1999.